_version_ 1785114179285286912
author Johnson, Natacha
Templé, Marie
Friedrich, Chloe
Willems, Lise
Birsen, Rudy
Vignon, Marguerite
Deschamps, Paul
Franchi, Patricia
Mondesir, Johanna
Deau-Fischer, Benedicte
Miekoutima, Elsa
Boussaid, Ismaël
Chapuis, Nicolas
Kosmider, Olivier
Bouscary, Didier
Tamburini, Jerome
Decroocq, Justine
author_facet Johnson, Natacha
Templé, Marie
Friedrich, Chloe
Willems, Lise
Birsen, Rudy
Vignon, Marguerite
Deschamps, Paul
Franchi, Patricia
Mondesir, Johanna
Deau-Fischer, Benedicte
Miekoutima, Elsa
Boussaid, Ismaël
Chapuis, Nicolas
Kosmider, Olivier
Bouscary, Didier
Tamburini, Jerome
Decroocq, Justine
author_sort Johnson, Natacha
collection PubMed
description
format Online
Article
Text
id pubmed-10542839
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Fondazione Ferrata Storti
record_format MEDLINE/PubMed
spelling pubmed-105428392023-10-03 Subcutaneous azacitidine maintenance in transplant-ineligible patients with acute myeloid leukemia: a single-center retrospective study Johnson, Natacha Templé, Marie Friedrich, Chloe Willems, Lise Birsen, Rudy Vignon, Marguerite Deschamps, Paul Franchi, Patricia Mondesir, Johanna Deau-Fischer, Benedicte Miekoutima, Elsa Boussaid, Ismaël Chapuis, Nicolas Kosmider, Olivier Bouscary, Didier Tamburini, Jerome Decroocq, Justine Haematologica Letter to the Editor Fondazione Ferrata Storti 2023-03-30 /pmc/articles/PMC10542839/ /pubmed/36994502 http://dx.doi.org/10.3324/haematol.2022.282009 Text en Copyright© 2023 Ferrata Storti Foundation https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (by-nc 4.0) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
spellingShingle Letter to the Editor
Johnson, Natacha
Templé, Marie
Friedrich, Chloe
Willems, Lise
Birsen, Rudy
Vignon, Marguerite
Deschamps, Paul
Franchi, Patricia
Mondesir, Johanna
Deau-Fischer, Benedicte
Miekoutima, Elsa
Boussaid, Ismaël
Chapuis, Nicolas
Kosmider, Olivier
Bouscary, Didier
Tamburini, Jerome
Decroocq, Justine
Subcutaneous azacitidine maintenance in transplant-ineligible patients with acute myeloid leukemia: a single-center retrospective study
title Subcutaneous azacitidine maintenance in transplant-ineligible patients with acute myeloid leukemia: a single-center retrospective study
title_full Subcutaneous azacitidine maintenance in transplant-ineligible patients with acute myeloid leukemia: a single-center retrospective study
title_fullStr Subcutaneous azacitidine maintenance in transplant-ineligible patients with acute myeloid leukemia: a single-center retrospective study
title_full_unstemmed Subcutaneous azacitidine maintenance in transplant-ineligible patients with acute myeloid leukemia: a single-center retrospective study
title_short Subcutaneous azacitidine maintenance in transplant-ineligible patients with acute myeloid leukemia: a single-center retrospective study
title_sort subcutaneous azacitidine maintenance in transplant-ineligible patients with acute myeloid leukemia: a single-center retrospective study
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10542839/
https://www.ncbi.nlm.nih.gov/pubmed/36994502
http://dx.doi.org/10.3324/haematol.2022.282009
work_keys_str_mv AT johnsonnatacha subcutaneousazacitidinemaintenanceintransplantineligiblepatientswithacutemyeloidleukemiaasinglecenterretrospectivestudy
AT templemarie subcutaneousazacitidinemaintenanceintransplantineligiblepatientswithacutemyeloidleukemiaasinglecenterretrospectivestudy
AT friedrichchloe subcutaneousazacitidinemaintenanceintransplantineligiblepatientswithacutemyeloidleukemiaasinglecenterretrospectivestudy
AT willemslise subcutaneousazacitidinemaintenanceintransplantineligiblepatientswithacutemyeloidleukemiaasinglecenterretrospectivestudy
AT birsenrudy subcutaneousazacitidinemaintenanceintransplantineligiblepatientswithacutemyeloidleukemiaasinglecenterretrospectivestudy
AT vignonmarguerite subcutaneousazacitidinemaintenanceintransplantineligiblepatientswithacutemyeloidleukemiaasinglecenterretrospectivestudy
AT deschampspaul subcutaneousazacitidinemaintenanceintransplantineligiblepatientswithacutemyeloidleukemiaasinglecenterretrospectivestudy
AT franchipatricia subcutaneousazacitidinemaintenanceintransplantineligiblepatientswithacutemyeloidleukemiaasinglecenterretrospectivestudy
AT mondesirjohanna subcutaneousazacitidinemaintenanceintransplantineligiblepatientswithacutemyeloidleukemiaasinglecenterretrospectivestudy
AT deaufischerbenedicte subcutaneousazacitidinemaintenanceintransplantineligiblepatientswithacutemyeloidleukemiaasinglecenterretrospectivestudy
AT miekoutimaelsa subcutaneousazacitidinemaintenanceintransplantineligiblepatientswithacutemyeloidleukemiaasinglecenterretrospectivestudy
AT boussaidismael subcutaneousazacitidinemaintenanceintransplantineligiblepatientswithacutemyeloidleukemiaasinglecenterretrospectivestudy
AT chapuisnicolas subcutaneousazacitidinemaintenanceintransplantineligiblepatientswithacutemyeloidleukemiaasinglecenterretrospectivestudy
AT kosmiderolivier subcutaneousazacitidinemaintenanceintransplantineligiblepatientswithacutemyeloidleukemiaasinglecenterretrospectivestudy
AT bouscarydidier subcutaneousazacitidinemaintenanceintransplantineligiblepatientswithacutemyeloidleukemiaasinglecenterretrospectivestudy
AT tamburinijerome subcutaneousazacitidinemaintenanceintransplantineligiblepatientswithacutemyeloidleukemiaasinglecenterretrospectivestudy
AT decroocqjustine subcutaneousazacitidinemaintenanceintransplantineligiblepatientswithacutemyeloidleukemiaasinglecenterretrospectivestudy